Health Subcommittee Hearing on Lowering Costs for Patients: The Health of the Biosimilar Market
Date:
Location:
1100 Longworth House Office Building
Witnesses
- Dr. Debra Patt, President, Community Oncology Alliance
- Dr. Colin Edgerton, Director, Articularis Healthcare Group
- Craig Burton, Executive Director, Biosimilars Council
- Dr. Aaron Kesselheim, Professor of Medicine, Harvard University
